english.prescrire.org > Spotlight > Archives : 2014 > In the November issue of Prescrire International: Artesunate - the standard intravenous treatment for severe attacks of malaria

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2014 : 1 | 30 | 60

In the November issue of Prescrire International: Artesunate - the standard intravenous treatment for severe attacks of malaria

FREE DOWNLOAD Plasmodium falciparum malaria can be life-threatening, particularly in young children, migrants, travellers and pregnant women. This sample page from the "New Products" section of the November issue sums up the factors that make intravenous artesunate the treatment of choice for severe attacks of Plasmodium falciparium malaria.
Full text available for free download.

Summary

  • Intravenous artesunate is more effective in reducing mortality than injectable quinine.
     
  • It also has a better adverse effect profile and is more convenient to use.
     
  • Full marketing authorisation in the EU would improve access to this drug.

Full text available for free download.

 ©Prescrire 1 November 2014

"Artesunate. The standard intravenous treatment for severe attacks of malaria" Prescrire Int 2014; 23 (154): 260. (Pdf, free)

 

 
Download the full review
Pdf, free

See also:

Artemisinin derivatives
and malaria. Useful,
in combination with
other antimalarials
Prescrire Int 2008:
17 (96): 162-168.
Pdf, subscribers only

Intravenous artesunate
for severe malaria
Prescrire Int 2008:
17 (96): 168-170.
Pdf, subscribers only